Guilford Street Laboratories


Guilford Street Laboratories is a UCL spin-out dedicated to advancing research through machine learning-driven mass spectrometry. They focus on delivering precise biomarker assays for early disease diagnosis, drug discovery, clinical trials, and personalized medicine, with a mission to revolutionize healthcare diagnostics and patient care.

Industries

biotechnology
life-science

Nr. of Employees

small (1-50)

Guilford Street Laboratories


Products

Multiplexed targeted biomarker panels (proteins, lipids, metabolites)

Multiplexed targeted panels for simultaneous quantitation of multiple protein, lipid, or metabolite biomarkers to support validation, diagnostics, and monitoring applications.

Mass spectrometry-based anti-drug antibody profiling platform

A mass spectrometry approach to quantify and subtype antibody responses (including subclass and isotype) to enzyme replacement therapies and viral vector gene therapies to inform clinical decision-making.


Services

Proteomics services (multiplexed targeted proteomic panels and discovery workflows)

Two-phase proteomic service offering untargeted discovery followed by high-throughput targeted confirmation and multiplexed targeted proteomic panels for biomarker validation and clinical translation.

Targeted lipid panel services

Targeted lipid analysis including lysosomal lipid analysis and neurolipid profiling to support diagnosis and monitoring of lysosomal storage disorders, cardiovascular and neurological diseases.

Metabolite assay services

Customisable metabolite assay development and execution including bile acid profiling and amino acid analysis, with feasibility consultation and bespoke assay development.

Anti-drug antibody profiling service

Mass spectrometry-based immune response profiling to quantify antibody subclass and isotype against protein therapeutics and gene therapy vectors for research and clinical monitoring.

Clinical assay implementation and validation support

Services to support clinical implementation of assays including regulated assay validation, integration of automated workflows, and development of digital reporting tools to enable clinical use and rapid turnaround.

Expertise Areas

  • Biomarker discovery and validation
  • Targeted proteomics
  • Untargeted proteomics
  • Lipidomics
  • Show More (6)

Key Technologies

  • Mass spectrometry
  • Targeted proteomics
  • Untargeted proteomics
  • Lipidomics
  • Show More (5)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.